Brainstorm Seminar Series II

Laurie H. Glimcher, M.D.  

President and CEO, Dana-Farber Cancer Institute

Richard and Susan Smith Professor of Medicine, Harvard Medical School

《The Future of Immunotherapy: Reprogramming the Tumor Microenvironment》


Wenru Song, M.D., Ph.D.

Co-Founder, President and Board Chair, Kira Pharmaceuticals.

Former Global VP, Immuno-Oncology Development at AstraZeneca.

《Cancer Immunotherapy: Unique Clinical Development Considerations》


Nancy Simonian, M.D. 

CEO, Syros Pharmaceuticals

Former CMO, Millennium Pharmaceuticals 

Vice President, Clinical Development at Biogen

《Targeting Non-coding Region for Cancer Therapy》


JULY 12, 2017, 18:30-20:30 EST

MIT Stata Center 32-141, Cambridge, MA